KLRK1 and breast carcinoma: However, because neoplastic cells often upregulate ligands for NKG2D, and because the addition of an NKG2D blocking antibody resulted in a partial reduction of MAIT cell effector responses, it is possible that the NKG2D pathway promotes the ability of MAIT cells to detect and respond to breast carcinomas.